AbbVie Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (14 lists). Names and jurisdictions are as filed.
- 2026-02-20: Subsidiary AbbVie Finance Corporation Delaware.
- 2026-02-20: Subsidiary AbbVie Respiratory LLC Delaware.
- 2026-02-20: Subsidiary AGN Sundry LLC Delaware.
- 2026-02-20: Subsidiary Allergan Pharma Inc. Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-02-20 | AbbVie Finance Corporation Delaware | |
| 2026-02-20 | AbbVie Respiratory LLC Delaware | |
| 2026-02-20 | AGN Sundry LLC Delaware | |
| 2026-02-20 | Allergan Pharma Inc. Delaware | |
| 2026-02-20 | Aptalis Pharma US, Inc. Delaware | |
| 2026-02-20 | Cerevel Therapeutics, Inc. Delaware | |
| 2026-02-20 | Hurricane, LLC Delaware | |
| 2026-02-20 | LifeCell Corporation Delaware | |
| 2026-02-20 | Pharmax Holding Limited Delaware | |
| 2026-02-20 | Topokine Therapeutics, Inc. Delaware | |
| 2026-02-20 | Foreign Subsidiaries Incorporation | |
| 2026-02-20 | AbbVie Ltd Bermuda | |
| 2026-02-20 | Allergan Holdings B2, Ltd. Bermuda | |
| 2026-02-20 | Aptalis Pharma Canada ULC Canada | |
| 2026-02-20 | Shanghai Allergan Medical Aesthetics Clinic Co. | |
| 2026-02-20 | Allergan Holdings France SAS France | |
| 2026-02-20 | AbbVie Limited Hong Kong | |
| 2026-02-20 | Allergan Equities Unlimited Company Ireland | |
| 2026-02-20 | Forest Laboratories Ireland Limited Ireland | |
| 2026-02-20 | Aptalis Pharma S.r.l. Italy | |
| 2026-02-20 | Allergan Capital S.à r.l. Luxembourg | |
| 2026-02-20 | Allergan Malta Holding Limited Malta | |
| 2026-02-20 | AbbVie Nederland Holdings B.V. Netherlands | |
| 2026-02-20 | AbbVie Philippines Inc. Philippines | |
| 2026-02-20 | AbbVie Operations Singapore Pte. Ltd. Singapore | |
| 2026-02-20 | Fastox Pharma SA Switzerland | |
| 2026-02-20 | AbbVie Ltd United Kingdom |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |